Epstein-Barr virus associated tumors and drug repurposing

A new study published in OMICS: A Journal of Integrative Biology identified differentially expressed host and viral microRNAs (miRNAs) in six Epstein-Barr virus (EBV) associated tumors. The study reports several drug candidates ...

Oncology & Cancer

Insights into the etiology of nasopharyngeal carcinoma

Nasopharyngeal carcinoma, NPC, is a rare tumor of the head and neck, which originates in the nasopharynx at the very back of the nose. NPC has a particularly high incidence in southern China, Southeast Asia, and North and ...

Diseases, Conditions, Syndromes

Analysis of EBV DNA in plasma samples IDs nasopharyngeal CA

(HealthDay)—Analysis of Epstein-Barr virus (EBV) DNA in plasma samples can identify early asymptomatic nasopharyngeal carcinoma, according to a study published in the Aug. 10 issue of the New England Journal of Medicine.


Pediatric nasopharyngeal CA has different patient demographic

(HealthDay)—Pediatric patients with nasopharyngeal carcinoma (NPC) are more often black and present with stage IV disease, but they have lower mortality than adult patients, according to a study published online Jan. 14 ...

Oncology & Cancer

Hematologic markers predict nasopharyngeal cancer survival

(HealthDay)—Pretreatment neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) may be predictors for survival in nasopharyngeal carcinoma, according to a study published online Sept. 11 in Head & Neck.

Oncology & Cancer

ERCC1 SNP can identify good prognosis in nasopharyngeal CA

(HealthDay)—Excision repair cross-complementing group 1 (ERCC1) genotype for the single nucleotide polymorphism (SNP) cytosine-to-thymine substitution at codon 118 (C118T) interacts with post-radiotherapy plasma Epstein-Barr ...

page 1 from 2